Research ArticleAdult Brain
Open Access
T1-Weighted Dynamic Contrast-Enhanced MRI as a Noninvasive Biomarker of Epidermal Growth Factor Receptor vIII Status
J. Arevalo-Perez, A.A. Thomas, T. Kaley, J. Lyo, K.K. Peck, A.I. Holodny, I.K. Mellinghoff, W. Shi, Z. Zhang and R.J. Young
American Journal of Neuroradiology December 2015, 36 (12) 2256-2261; DOI: https://doi.org/10.3174/ajnr.A4484
J. Arevalo-Perez
aFrom the Departments of Radiology (J.A.-P., J.L., A.I.H., R.J.Y.)
A.A. Thomas
bNeurology (A.A.T., T.K., I.K.M.)
T. Kaley
bNeurology (A.A.T., T.K., I.K.M.)
ethe Brain Tumor Center (T.K., J.L., A.I.H., R.J.Y.), Memorial Sloan Kettering Cancer Center, New York, New York.
J. Lyo
aFrom the Departments of Radiology (J.A.-P., J.L., A.I.H., R.J.Y.)
ethe Brain Tumor Center (T.K., J.L., A.I.H., R.J.Y.), Memorial Sloan Kettering Cancer Center, New York, New York.
K.K. Peck
cMedical Physics (K.K.P.)
A.I. Holodny
aFrom the Departments of Radiology (J.A.-P., J.L., A.I.H., R.J.Y.)
ethe Brain Tumor Center (T.K., J.L., A.I.H., R.J.Y.), Memorial Sloan Kettering Cancer Center, New York, New York.
I.K. Mellinghoff
bNeurology (A.A.T., T.K., I.K.M.)
W. Shi
dEpidemiology and Biostatistics (W.S., Z.Z.)
Z. Zhang
dEpidemiology and Biostatistics (W.S., Z.Z.)
R.J. Young
aFrom the Departments of Radiology (J.A.-P., J.L., A.I.H., R.J.Y.)
ethe Brain Tumor Center (T.K., J.L., A.I.H., R.J.Y.), Memorial Sloan Kettering Cancer Center, New York, New York.

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
American Journal of Neuroradiology
Vol. 36, Issue 12
1 Dec 2015
Advertisement
J. Arevalo-Perez, A.A. Thomas, T. Kaley, J. Lyo, K.K. Peck, A.I. Holodny, I.K. Mellinghoff, W. Shi, Z. Zhang, R.J. Young
T1-Weighted Dynamic Contrast-Enhanced MRI as a Noninvasive Biomarker of Epidermal Growth Factor Receptor vIII Status
American Journal of Neuroradiology Dec 2015, 36 (12) 2256-2261; DOI: 10.3174/ajnr.A4484
T1-Weighted Dynamic Contrast-Enhanced MRI as a Noninvasive Biomarker of Epidermal Growth Factor Receptor vIII Status
J. Arevalo-Perez, A.A. Thomas, T. Kaley, J. Lyo, K.K. Peck, A.I. Holodny, I.K. Mellinghoff, W. Shi, Z. Zhang, R.J. Young
American Journal of Neuroradiology Dec 2015, 36 (12) 2256-2261; DOI: 10.3174/ajnr.A4484
Jump to section
Related Articles
- No related articles found.
Cited By...
- Structural and practical identifiability of contrast transport models for DCE-MRI
- Tumor-Derived Pericytes Driven by EGFR Mutations Govern the Vascular and Immune Microenvironment of Gliomas
- The genetic status of IDH1/2 and EGFR dictates the vascular landscape and the progression of gliomas
- In Vivo Detection of EGFRvIII in Glioblastoma via Perfusion Magnetic Resonance Imaging Signature Consistent with Deep Peritumoral Infiltration: The {varphi}-Index
- Diagnostic Accuracy of T1-Weighted Dynamic Contrast-Enhanced-MRI and DWI-ADC for Differentiation of Glioblastoma and Primary CNS Lymphoma
- Automated Processing of Dynamic Contrast-Enhanced MRI: Correlation of Advanced Pharmacokinetic Metrics with Tumor Grade in Pediatric Brain Tumors
- T1-Weighted Dynamic Contrast-Enhanced MRI Is a Noninvasive Marker of Epidermal Growth Factor Receptor vIII Status in Cancer Stem Cell-Derived Experimental Glioblastomas
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Similar Articles
Advertisement